Antigenicity and immunogenicity of HA2 and M2e influenza virus antigens conjugated to norovirus-like, VP1 capsid-based particles by the SpyTag/SpyCatcher technology

Modular vaccine platform based on the norovirus-like particle

(2021) Vili Lampinen et al.   JOURNAL OF NANOBIOTECHNOLOGY

Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates

(2021) Nicole Darricarrère et al.   Science Translational Medicine

Rotavirus as an Expression Platform of Domains of the SARS-CoV-2 Spike Protein

(2021) Asha Ann Philip et al.   Vaccines

Fusion Protein of Rotavirus VP6 and SARS-CoV-2 Receptor Binding Domain Induces T Cell Responses

(2021) Kirsi Tamminen et al.   Vaccines

Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo

(2020) Kirsi Tamminen et al.   Journal of Immunology Research

Virology, Epidemiology, Pathogenesis, and Control of COVID-19

(2020) Yuefei Jin et al.   Viruses-Basel

Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only

(2020) Suvi Heinimäki et al.   Vaccines

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

(2020) Raffael Nachbagauer et al.   NATURE MEDICINE

Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses

(2018) Lei Deng et al.   Nature Communications

Bioengineered Norovirus S60 Nanoparticles as a Multifunctional Vaccine Platform

(2018) Ming Xia et al.   ACS Nano

Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera

(2018) Maria Malm et al.   VIRAL IMMUNOLOGY

Vaccine technologies: From whole organisms to rationally designed protein assemblies

(2016) Christopher P. Karch et al.   BIOCHEMICAL PHARMACOLOGY

Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization

(2016) Karl D. Brune et al.   Scientific Reports

His-tagged norovirus-like particles: A versatile platform for cellular delivery and surface display

(2015) Tiia Koho et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial

(2015)   LANCET

A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice

(2015) Liping Jiang et al.   VACCINE

Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assays

(2014) Hanni Uusi-Kerttula et al.   MICROBES AND INFECTION

Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection

(2014) V. V. A. Mallajosyula et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The highly conserved HA2 protein of the influenza a virus induces a cross protective immune response

(2013) Jong-Soo Lee et al.   JOURNAL OF VIROLOGICAL METHODS

Modular engineering of a microbially-produced viral capsomere vaccine for influenza

(2012) Nani Wibowo et al.   CHEMICAL ENGINEERING SCIENCE

Design of Escherichia coli-Expressed Stalk Domain Immunogens of H1N1 Hemagglutinin That Protect Mice from Lethal Challenge

(2012) G. Bommakanti et al.   JOURNAL OF VIROLOGY

Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin

(2012) B. Zakeri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

(2012) Natasha Kushnir et al.   VACCINE

A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles

(2011) Kirsi Tamminen et al.   IMMUNOLOGY

Prevalence of norovirus GII-4 antibodies in Finnish children

(2011) K. Nurminen et al.   JOURNAL OF MEDICAL VIROLOGY

Norovirus Vaccine against Experimental Human Norwalk Virus Illness

(2011) Robert L. Atmar et al.   NEW ENGLAND JOURNAL OF MEDICINE

A candidate dual vaccine against influenza and noroviruses

(2011) Ming Xia et al.   VACCINE

Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis

(2011) Vesna Blazevic et al.   VACCINE

A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles

(2010) L. Huhti et al.   ARCHIVES OF VIROLOGY

Heat-Stable Enterotoxin of Enterotoxigenic Escherichia coli as a Vaccine Target

(2010) A. Taxt et al.   INFECTION AND IMMUNITY

Serological Correlate of Protection against Norovirus‐Induced Gastroenteritis

(2010) Amanda Reeck et al.   JOURNAL OF INFECTIOUS DISEASES

Norovirus P Particle, a Novel Platform for Vaccine Development and Antibody Production

(2010) M. Tan et al.   JOURNAL OF VIROLOGY

Versatile Virus-Like Particle Carrier for Epitope Based Vaccines

(2010) Alain C. Tissot et al.   PLoS One

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge

(2010) G. Bommakanti et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Chimeric recombinant rotavirus-like particles as a vehicle for the display of heterologous epitopes

(2009) Andrea Peralta et al.   Virology Journal

Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres

(2009) Yoshihiko Murata et al.   Virology Journal